from PR Newswire
from PR Newswire
Srinivas Akkaraju Joins Sofinnova Ventures as General Partner; Anand Mehra Promoted to General Partner Read More
from PR Newswire
KaloBios to Present at Needham Healthcare Conference
April 24, 2013
from PR Newswire
U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa
April 23, 2013
from PR Newswire
KaloBios' Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
April 17, 2013
from PR Newswire
IPO Performance of 2013: Check Out Winners and Losers
April 17, 2013
2013 has been a strong year for IPO performance so far. About 40 deals have been priced through the second week of April, and 33 of the deals have moved higher in the secondary market with an average... Read More
from Money Morning
Top Performing Industries For April 15, 2013
April 15, 2013
from PR Newswire
KaloBios Announces Fiscal Year 2012 Financial Results
March 27, 2013
from PR Newswire
from PR Newswire
from PR Newswire
Leerink Swann Starts KaloBios Pharmaceuticals (KBIO) at Outperform
February 26, 2013
William Blair Starts KaloBios Pharmaceuticals (KBIO) at Outperform
February 26, 2013
Major Drug Manufacturers Stocks Alert: Impax Laboratories Inc, Aegerion Pharmaceuticals, KaloBios Pharmaceuticals Inc, Ampio Pharmaceuticals
February 22, 2013
Stocks Hitting 52-Week Lows
February 13, 2013
KaloBios Pharmaceuticals Completes Initial Public Offering
February 07, 2013
from PR Newswire
Tuesday 2/5 Insider Buying Report: TGI, KBIO
February 05, 2013
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. Read More
category
Stocks
from Market News Video
KaloBios Pharmaceuticals Announces Pricing of IPO
January 31, 2013
KaloBios Pharmaceuticals (KBIO) announced the pricing of its previously announced IPO of 8,750,000 shares of common stock at a price to the public of $8.00 per share, less underwriting discounts and... Read More
category
Stocks
from Market News Video
KaloBios Pharmaceuticals (KBIO) Prices 8.75M IPO at $8/Share
January 31, 2013
from PR Newswire
Zoetis: The Biggest IPO Since Facebook
January 28, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here